
Craig R. Feinberg
Examiner (ID: 11177)
| Most Active Art Unit | 3402 |
| Art Unit(s) | 3402 |
| Total Applications | 487 |
| Issued Applications | 440 |
| Pending Applications | 0 |
| Abandoned Applications | 47 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 501905
[patent_doc_number] => 07205432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => 'Process for the preparation of adamantane derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/139624
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2505
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/205/07205432.pdf
[firstpage_image] =>[orig_patent_app_number] => 11139624
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/139624 | Process for the preparation of adamantane derivatives | May 30, 2005 | Issued |
Array
(
[id] => 7020177
[patent_doc_number] => 20050222196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 11/137912
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58536
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11137912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/137912 | Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease | May 25, 2005 | Abandoned |
Array
(
[id] => 6967195
[patent_doc_number] => 20050234092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 11/139066
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58490
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234092.pdf
[firstpage_image] =>[orig_patent_app_number] => 11139066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/139066 | Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease | May 25, 2005 | Abandoned |
Array
(
[id] => 528444
[patent_doc_number] => 07183422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-27
[patent_title] => 'Oxonol compound and process for producing the compound'
[patent_app_type] => utility
[patent_app_number] => 10/559392
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5976
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183422.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559392
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559392 | Oxonol compound and process for producing the compound | May 25, 2005 | Issued |
Array
(
[id] => 4786497
[patent_doc_number] => 20080139826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Method For Manufacturing Fullerene Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/569571
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4631
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139826.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569571
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569571 | Method for manufacturing fullerene derivatives | May 25, 2005 | Issued |
Array
(
[id] => 4960833
[patent_doc_number] => 20080275258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Epigallocatechin Dimers or Trimers Having Lipase Inhibitory Activity and/or Antioxidant Activity'
[patent_app_type] => utility
[patent_app_number] => 11/597291
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4611
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275258.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597291
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597291 | Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity | May 25, 2005 | Issued |
Array
(
[id] => 4705069
[patent_doc_number] => 20080064593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-13
[patent_title] => 'Multi-Layer Catalyst for Producing Phthalic Anhydride'
[patent_app_type] => utility
[patent_app_number] => 11/597307
[patent_app_country] => US
[patent_app_date] => 2005-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8418
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20080064593.pdf
[firstpage_image] =>[orig_patent_app_number] => 11597307
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/597307 | Multi-layer catalyst for producing phthalic anhydride | May 21, 2005 | Issued |
Array
(
[id] => 5626142
[patent_doc_number] => 20060264647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Separation of tetrahydrocannabinols'
[patent_app_type] => utility
[patent_app_number] => 11/132251
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1794
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264647.pdf
[firstpage_image] =>[orig_patent_app_number] => 11132251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/132251 | Separation of tetrahydrocannabinols | May 18, 2005 | Issued |
Array
(
[id] => 5310832
[patent_doc_number] => 20090018113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-15
[patent_title] => 'Novel Cylopenta[B]Benzofuran Derivatives and the Utilization Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/596907
[patent_app_country] => US
[patent_app_date] => 2005-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42589
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20090018113.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596907
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596907 | Cylopenta[b]benzofuran derivatives and the utilization thereof | May 13, 2005 | Issued |
Array
(
[id] => 7055970
[patent_doc_number] => 20050277144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Compounds and methods for fluorescent labeling'
[patent_app_type] => utility
[patent_app_number] => 11/127040
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24634
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127040
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127040 | Compounds and methods for fluorescent labeling | May 9, 2005 | Issued |
Array
(
[id] => 7189285
[patent_doc_number] => 20050192446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Polymer compounds containing oxetane and styrenic functionality'
[patent_app_type] => utility
[patent_app_number] => 11/120585
[patent_app_country] => US
[patent_app_date] => 2005-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1889
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120585 | Polymer compounds containing oxetane and styrenic functionality | May 2, 2005 | Issued |
Array
(
[id] => 4604769
[patent_doc_number] => 07985749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-26
[patent_title] => 'Compounds and compositions as cathepsin S inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/568459
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15943
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/985/07985749.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568459
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568459 | Compounds and compositions as cathepsin S inhibitors | Apr 28, 2005 | Issued |
Array
(
[id] => 813852
[patent_doc_number] => 07414126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'Process for the preparation of topiramate'
[patent_app_type] => utility
[patent_app_number] => 11/117408
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5054
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/414/07414126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11117408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/117408 | Process for the preparation of topiramate | Apr 28, 2005 | Issued |
Array
(
[id] => 7112022
[patent_doc_number] => 20050209478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Polydioxaborines'
[patent_app_type] => utility
[patent_app_number] => 11/110314
[patent_app_country] => US
[patent_app_date] => 2005-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10859
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209478.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110314 | Polydioxaborines | Apr 19, 2005 | Abandoned |
Array
(
[id] => 7051523
[patent_doc_number] => 20050187410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Mesoporous material and use thereof for the selective oxidation of organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/108452
[patent_app_country] => US
[patent_app_date] => 2005-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3898
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11108452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/108452 | Mesoporous material and use thereof for the selective oxidation of organic compounds | Apr 17, 2005 | Abandoned |
Array
(
[id] => 7234419
[patent_doc_number] => 20050256184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => '1,2,4-Trioxanes and 1,2,4-trioxepanes'
[patent_app_type] => utility
[patent_app_number] => 11/103076
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9394
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256184.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103076 | 1,2,4-Trioxanes and 1,2,4-trioxepanes | Apr 10, 2005 | Abandoned |
Array
(
[id] => 5231359
[patent_doc_number] => 20070293467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Demethyl-Cantharidin Platinum Complex Isomers and Their Use'
[patent_app_type] => utility
[patent_app_number] => 11/578002
[patent_app_country] => US
[patent_app_date] => 2005-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4534
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578002
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578002 | Demethyl-Cantharidin Platinum Complex Isomers and Their Use | Apr 7, 2005 | Abandoned |
Array
(
[id] => 5436339
[patent_doc_number] => 20090170926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/594847
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13915
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594847 | Antiviral agents | Mar 30, 2005 | Abandoned |
Array
(
[id] => 4803643
[patent_doc_number] => 20080015232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'SCHWEINFURTHIN ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 11/093270
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17777
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015232.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093270
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093270 | Schweinfurthin analogues | Mar 28, 2005 | Issued |
Array
(
[id] => 645794
[patent_doc_number] => 07119212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-10
[patent_title] => 'Process for the preparation of tolterodine and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 11/092553
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2707
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/119/07119212.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092553 | Process for the preparation of tolterodine and intermediates thereof | Mar 28, 2005 | Issued |